Advances in prophylactic cancer vaccine research

I. Caroline Le Poole*, Hemamalini Bommiasamy, Maurizio Bocchetta, W. Martin Kast

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review


Prophylactic vaccination against human cancer provides a unique opportunity to prevent human suffering for individuals at risk for tumor development. Appropriate vaccines may pose slightly different requirements than vaccines intended for therapeutic use. Prophylactic vaccines will need to prevent tumors far into the future, emphasizing the need to establish solid tumor-specific immunologic memory. Another important issue associated with prophylactic cancer vaccines is the identification of appropriate populations for vaccination. Individuals at risk may include those exposed to oncogenic viruses, those with occupational exposure to tumor promoting agents, and individuals with a family history of cancer. This paper addresses the specific challenges posed to the exciting field of prophylactic cancer vaccine research.

Original languageEnglish (US)
Pages (from-to)537-545
Number of pages9
JournalExpert review of anticancer therapy
Issue number4
StatePublished - Aug 2003


  • Immune monitoring
  • Memory T-cell response
  • Safety
  • Spontaneous tumor models tumor-associated antigen vaccine
  • Viral oncoger

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Oncology


Dive into the research topics of 'Advances in prophylactic cancer vaccine research'. Together they form a unique fingerprint.

Cite this